To this respect, it has been described that prolactin administered in high doses alters the signaling mechanism through which glucose enters pancreatic β cells and therefore disrupts adequate insulin response to glucose which may finally lead to glucose intolerance (72) (27). This evidence concerns the gene PRL and Glucose intolerance.